Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Belloff Neil S. Create: Alert

All | News | Filings
Date FiledTypeDescription
04/04/2023 4 Belloff Neil S. (General Counsel and Corp Secy) has filed a Form 4 on Acorda Therapeutics, Inc.
Txns: Granted 77,300 options to buy @ $0.586, valued at $45.3k
11/09/2021 4 Belloff Neil S. (General Counsel) has filed a Form 4 on ACORDA THERAPEUTICS INC
Txns: Granted 85,000 options to buy @ $3.74, valued at $317.9k
07/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2020 4 Belloff Neil S. (COO, GENERAL COUNSEL &CORP SEC) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 459 shares @ $2.53, valued at $1.2k
Exercised 1,562 restricted stock units @ $0
07/31/2020 4 Belloff Neil S. (COO, GENERAL COUNSEL &CORP SEC) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 459 shares @ $2.84, valued at $1.3k
Exercised 1,563 restricted stock units @ $0
05/01/2020 4 Belloff Neil S. (COO, GENERAL COUNSEL &CORP SEC) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 459 shares @ $2.92, valued at $1.3k
Exercised 1,562 restricted stock units @ $0
02/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2020 4 Belloff Neil S. (GENERAL COUNSEL/CORPORATE SECR) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 2,166 shares @ $3.91, valued at $8.5k
Exercised 6,250 restricted stock units @ $0
09/13/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/31/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/20/2018 4 Belloff Neil S. (General Counsel and Secretary) has filed a Form 4 on Eloxx Pharmaceuticals, Inc.
Txns: Granted 125,000 options to buy @ $20.85, valued at $2.6M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy